Iris Gorfinkel
HopeHealth(US)
Publications by Year
Research Areas
Herpesvirus Infections and Treatments, Pharmaceutical Practices and Patient Outcomes, Poxvirus research and outbreaks, Vaccine Coverage and Hesitancy, Acne and Rosacea Treatments and Effects
Most-Cited Works
- → Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older(2016)1,017 cited
- → Efficacy Results of a Trial of a Herpes Simplex Vaccine(2012)506 cited
- → Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination(2022)98 cited
- → The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70(2021)91 cited
- → Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials(2019)62 cited
- → Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials(2019)48 cited
- → A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness(2011)31 cited
- → Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials(2019)28 cited
- → Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients(2024)13 cited
- → Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial(2013)11 cited